Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was unusually long for many on this side of the pond — was relaxing and refreshing, because that predictable routine of meetings, deadlines, and phone calls has, once again, returned. What can you do? The world keeps spinning, no matter how hard we try to slow it down. So, time to grab a cup of stimulation and get cracking. Toward that end, here are some tidbits to get you going. Hope your day is splendid and do keep in touch. …

The U.S. wants Switzerland to extradite Chinese researcher Gongda Xue, who is accused of helping his scientist sister steal secrets worth $550 million from GlaxoSmithKline (GSK), Reuters reports. Gongda Xue, who is fighting extradition, has been labeled a potential flight risk, according to a Swiss Federal Criminal Court verdict, keeping him in custody pending the resolution of the extradition request. Last year, his sister, the Chinese-American scientist Yu Xue, pleaded guilty to pilfering secrets from Glaxo, where she worked until 2016.


President Trump says his administration is “working on” a system to allow the U.S. to buy drugs based on the lowest prices paid by other countries, STAT writes. Known as an International Pricing Index, the proposal would allow Medicare to set prices for drugs in the Part B program based on prices paid by other countries. The idea, which the Department of Health and Human Services has forecast would save the federal government $17.2 billion over five years, is under review by the federal government.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!